Bavarian Biotech Report 2011/2012 (7MB) - Bio M
Share Embed Flag
Download ePaper

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Bavarian Biotech Report 2011/2012 (7MB) - Bio M Bavarian Biotech Report 2011/2012 (7MB) - Bio M

m4.de
13.07.2015 Views

Contact:Peter Paul SchikoraMühlfeld 9D-83324 RuhpoldingPhone: +49 (0) 8663 41800-0Fax: +49 (0) 8663 41800-99E-Mail: info@glucometrix.deInternet: www.glucometrix.deGLUCOMETRIX AGBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Diabetics, Drug Development, Devices, Chip / Array Technology,Peptide/ProteinKey Figures:GlucoMetrix AG was founded in 2001. It has 3 major subsidiaries that concentrateon different aspects of enhancing the quality of life for peoplesuffering from diabetesGlucoMetrix NIB GmbH develops medical devices for measuring bloodsugar non-invasively, i.e. without puncturing the skinGlucoMetrix PVS GmbH develops a new production method for insulinwhich promises a purer insulin with less side effectsGlucoMetrix Pharma VV GmbH develops, manufactures and marketsmedicinal products related to wound healing. These are particularly suitedfor diabetic woundsProducts and Technologies:Development of expression platforms for biomedical products andDevelopment of downstream purification methodsBIOSept line of wound treatment productsMajor R&D Topics:Opto-acoustical device to measure blood sugar non-invasively (in collaborationwith ETH Zurich)Immunological assay to determine glycated serum proteins (POC-assay;in collaboration with FHI BMT)Genetic predisposition for diabetes mellitusCost-effective production methods for human insulinHarrison Clinical Research DeutschlandGmbHCROContact:Volker KnorzAlbrechtstr. 14D-80636 MünchenPhone: +49 (0) 89 126680-0Fax: +49 (0) 89 126680-2444E-Mail: Volker.Knorz@harrison-cro.comInternet: www.harrisonclinical.comKeywords: Cardiovascular Diseases, CNS, Metabolic Diseases, Nephrology,Oncology, Pain, Clinical Research, MonitoringHarrison Clinical Research is an independent ISO 9001 certified CRO foundedin 1987 in Munich with offices in UK, Belgium, Israel, Spain, Italy,France, Austria, Poland, Denmark, Sweden, Ukraine, Russia, USA and partnersin Asia and Australia. Our team comprises more than 500 research professionals.We offer all services required for the clinical development andregistration of new pharmaceutical products/medical devices: Internationalproject management, monitoring, data management, statistics, medical writing,auditing, training and outsourcing.Apart from conduct of standard Phase I studies, our Phase I/IIa clinic isspecialised in proof-of-concept studies in special patient populations andefficacy studies in various indications. For more information please visitwww.harrisonclinical.com68

Haupt Pharma Sales GmbHCMOKeywords: Full service contract development and manufacturing, Clinical TrailSupply Services, Cytotoxics, Hormones, high potent APIsWith nine production sites in Germany, France, Italy and Japan and a representativeoffice in the USA, Haupt Pharma is one of the leading contractdevelopers and manufacturers in Europe. With our full service, which coverspharmaceutical development, materials procurement, commercial production,packaging and distribution, we will manage important sections of yourvalue chain. Haupt Pharma provides a technology that covers most pharmaceuticaldosage forms, with a special expertise in sterile products and lyophilizedformulations. In addition to conventional APIs, we handle cytostatics,hormones, beta-lactam antibiotics and controlled drugs. Apart frompharmaceuticals (ethical and OTC), our portfolio includes veterinary medicinalproducts, dietary supplements and cosmetics. We serve regulated marketsworldwide, with a particular focus on Europe, USA and Japan. Morethan 200 customers, among them many global players, rely on HauptPharma's manufacturing, development and clinical trial supply services.Contact:Christian SchmittPfaffenrieder Str. 5-7D-82515 WolfratshausenPhone: +49 (0) 8171 414 150Fax: +49 (0) 8171 414 109E-Mail:Christian.Schmitt@haupt-pharma.deInternet: www.haupt-pharma.deHematris Wound Care GmbHMEDTECHKeywords: DevicesHematris Wound Care GmbH develops, manufactures and markets productsin the area of wound care. Our major initial focus is the marketing of hemostaticproducts to control bleeding.We are experts in the field of hemostasis and wound healing. Our vision isto build up an attractive company together with our investors in this businessarea.Contact:Dr. Dr. Stefan BertschProfessor-Messerschmitt-Str. 3D-85579 NeubibergPhone: +49 (0) 89 6008761-0Fax: +49 (0) 89 6008761-24E-Mail: bertsch@hematris.deInternet: www.hematris.deHepa Wash GmbHMEDTECHKeywords: Hepatology, DevicesThe Hepa Wash GmbH is a medical device company developing a new liverassist device for the treatment of patient with life-threatening liver disease.Main features of Hepa Washs extracorporeal technology are its highlyefficiency albumin-dialysis and its innovative albumin regeneration circuit.Hepa Wash is dedicated to developing a therapy that is several times moreeffective than currently available treatments and to significantly increase thesurvival rate and quality of live of patients with life-threatening liver disease.Contact:PD Dr. Bernhard KreymannAgnes-Pockels-Bogen 1D-80992 MünchenPhone: +49 (0) 89 4111842-0Fax: +49 (0) 89 4111842-09Internet: www.hepawash.com69

Contact:Peter Paul SchikoraMühlfeld 9D-83324 RuhpoldingPhone: +49 (0) 8663 41800-0Fax: +49 (0) 8663 41800-99E-Mail: info@glucometrix.deInternet: www.glucometrix.deGLUCOMETRIX AGBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Diabetics, Drug Development, Devices, Chip / Array Technology,Peptide/ProteinKey Figures:GlucoMetrix AG was founded in 2001. It has 3 major subsidiaries that concentrateon different aspects of enhancing the quality of life for peoplesuffering from diabetesGlucoMetrix NIB GmbH develops medical devices for measuring bloodsugar non-invasively, i.e. without puncturing the skinGlucoMetrix PVS GmbH develops a new production method for insulinwhich promises a purer insulin with less side effectsGlucoMetrix Pharma VV GmbH develops, manufactures and marketsmedicinal products related to wound healing. These are particularly suitedfor diabetic woundsProducts and Technologies:Development of expression platforms for biomedical products andDevelopment of downstream purification methodsBIOSept line of wound treatment productsMajor R&D Topics:Opto-acoustical device to measure blood sugar non-invasively (in collaborationwith ETH Zurich)Immunological assay to determine glycated serum proteins (POC-assay;in collaboration with FHI BMT)Genetic predisposition for diabetes mellitusCost-effective production methods for human insulinHarrison Clinical Research DeutschlandGmbHCROContact:Volker KnorzAlbrechtstr. 14D-80636 MünchenPhone: +49 (0) 89 126680-0Fax: +49 (0) 89 126680-2444E-Mail: Volker.Knorz@harrison-cro.comInternet: www.harrisonclinical.comKeywords: Cardiovascular Diseases, CNS, Metabolic Diseases, Nephrology,Oncology, Pain, Clinical Research, MonitoringHarrison Clinical Research is an independent ISO 9001 certified CRO foundedin 1987 in Munich with offices in UK, Belgium, Israel, Spain, Italy,France, Austria, Poland, Denmark, Sweden, Ukraine, Russia, USA and partnersin Asia and Australia. Our team comprises more than 500 research professionals.We offer all services required for the clinical development andregistration of new pharmaceutical products/medical devices: Internationalproject management, monitoring, data management, statistics, medical writing,auditing, training and outsourcing.Apart from conduct of standard Phase I studies, our Phase I/IIa clinic isspecialised in proof-of-concept studies in special patient populations andefficacy studies in various indications. For more information please visitwww.harrisonclinical.com68

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!